article thumbnail

Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle

Journal of the American Heart Association

Despite significant advances in the diagnosis, prognostication, and treatment of thrombotic diseases over the past 3 decades, the adoption of findings stemming from translational biomarker research in clinical practice remains limited. We sought to provide an overview of biomarker research in arterial and venous thromboembolic disease.

article thumbnail

Causal Associations of Education Level With Cardiovascular Diseases, Cardiovascular Biomarkers, and Socioeconomic Factors

The American Journal of Cardiology

An inverse association of education level with cardiovascular diseases has been documented in observational studies, yet the causality and potential m…

article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

His unwavering dedication and contributions to CMHC as a renowned expert, educator, and mentor in the cardiorenal metabolic space have left an indelible mark on our community. This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L.

Education 100
article thumbnail

Abstract TP49: Establishing a Cell Type-Specific Extracellular Vesicle Isolation Workflow For Improved Biomarker Discovery

Stroke Journal

Analysis of extracellular vesicles (EVs), important constituents of the intercellular communication pathway, may offer new ways to evaluate pathological processes of sCVD as well as serve as novel biomarkers or identify new avenues for therapy. years of education. years of education.

article thumbnail

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

Journal of Clinical Investigation - Cardiology

These results show promising potential for examining crizanlizumab in larger studies of RVCL-S and similar small-vessel diseases and for using the retina as a biomarker for systemic disease.Trial registration ClinicalTrials.gov NCT04611880.FUNDING FUNDING The Clayco Foundation; DeNardo Education and Research Foundation Grant; Jeffrey T.

article thumbnail

Genetesis Launches CardioFlux Membership Program

DAIC

The current version of the CardioFlux Score analyzes 14 unique biomarkers that quantify the heart muscle's electrical activity and then compares those results to a benchmark of healthy, symptom-free individuals.

article thumbnail

FDA Approves Digital Health Solution for Heart Failure Management

DAIC

platform, supported by educational content from the American Heart Association, and a dedicated clinical review team. Digitiva is comprised of three components: the CORE 500 Digital Stethoscope developed by Eko Health Inc., a smartphone app designed for heart failure patients and built on the Welldoc, Inc.